Calithera Biosciences Q3 EPS $(0.38) Beats $(0.45) Estimate

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.45) by 15.56 percent. This is a 26.92 percent increase over losses of $(0.52) per share

Benzinga · 11/12/2019 21:37

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.45) by 15.56 percent. This is a 26.92 percent increase over losses of $(0.52) per share from the same period last year.